medpageToday
Treatment of neuromyelitis optica with a personalized regimen of rituximab (Rituxan) was effective in long-term disease suppression, a retrospective Korean study found.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.
Learn more about writing for us